Dr. Nagourney's Blog

Email-box.png

Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Serendipity Saves a Life for a Patient with Advanced Breast Cancer
By Robert A. Nagourney, MD
In early September of 2018, I consulted with a 51-year-old patient with heavily pre-treated, extremely advanced metastatic breast cancer. Diagnosed 5 years earlier, the tumor was managed by targeting the HER-2 oncogene identified in her...
In Medical Oncology Logic Prevails (Finally)
By Robert A. Nagourney, MD
  Breast cancer remains a challenging public health issue, with 231,000 new diagnoses and 40,290 deaths in the US in 2015....
Future (Cancer) Shock - HSP90 Inhibitors
By Robert A. Nagourney, MD
Two related clinical trials were reported in the last several months describing the use of heat shock protein 90 (HSP90)...
Every Cancer Patient Outcome is Important - Stage 4 Stomach Cancer
By Robert A. Nagourney, MD
Clinical oncologists can be divided into different camps. There are those who see patient outcomes as a means-to-an-end. Each...
Gastric (Stomach) Cancer: A Call for Patient Selection
By Robert A. Nagourney, MD
Gastric (stomach) cancer is the fourth most common cancer worldwide with more than 930,000 diagnoses and 800,000 deaths...
Two Lung Cancer Trials Fall Short but Still Hope for HSP90 Inhibitors
By Robert A. Nagourney, MD
Two related clinical trials were reported in the last several months describing the use of heat shock protein 90 (HSP90)...
HER2 in Stomach Cancer and Breast Cancer
By Robert A. Nagourney, MD
I met a charming patient in my office this week. A gentleman with advanced gastric (stomach) cancer. Upon further examination...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.